SCHEMBL7811178

SCHEMBL7811178

c1ccc(COC2NCCc3ccccc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PRCP P42785 8/20 0.56
SLC22A1 O15245 1/20 0.56
GAA P10253 2/20 0.49
CYP2C19 P33261 1/20 0.46
TSHR P16473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
GID4 Q8IVV7 1/20 0.42
RECQL P46063 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30199336 0.85 CHRM2 (0.47) PRCPSLC22A1GAARECQL
SCHEMBL30199293 0.83 ALDH1A1 (0.44) PRCPSLC22A1GAATSHRNPSR1
SCHEMBL987517 0.81 PRCP (0.51) PRCPSLC22A1GAATSHRNPSR1
SCHEMBL30199123 0.80 PRCP (0.44) PRCPSLC22A1GAATSHRNPSR1
SCHEMBL30199729 0.79 PRCP (0.39) PRCPSLC22A1TSHRNPSR1
SCHEMBL28495268 0.78 PRCP (0.47) PRCPSLC22A1GAATSHRNPSR1
SCHEMBL8813918 0.78 GID4 (0.49) PRCPSLC22A1GAATSHRNPSR1
Acetonitrile SCHEMBL9306677 0.77 CTSL (0.41) PRCPSLC22A1CYP2C19
SCHEMBL10571581 0.76 PRCP (0.44) PRCPSLC22A1GAATSHRNPSR1
SCHEMBL10796144 0.76 HTR2C (0.50) PRCPSLC22A1GAACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107793356-A A kind of salt derivative of tetrahydroisoquinoline and its preparation method and application of crystal 上海医药工业研究院 2018-03-13 CN claimed
EP-1163225-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2001-12-19 EP disclosed
WO-2000055137-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed